- P-ISSN 2233-4203
- E-ISSN 2093-8950
- P-ISSN2233-4203
- E-ISSN2093-8950
- ESCI, SCOPUS, KCI
Article Detail
Home > Article Detail
A Fast Determination of Globotriaosylsphingosine in Plasma for Screening Fabry Disease Using UPLC-ESI-MS/MS
Mass Spectrometry Letters / Mass Spectrometry Letters, (P)2233-4203; (E)2093-8950
2015, v.6 no.4, pp.116-119
https://doi.org/10.5478/MSL.2015.6.4.116
(Duksung Women’s University)
Yoon,
H.
(2015). A Fast Determination of Globotriaosylsphingosine in Plasma for Screening Fabry Disease Using UPLC-ESI-MS/MS. , 6(4), 116-119, https://doi.org/10.5478/MSL.2015.6.4.116
- 524Downloaded
- 841Viewed
Abstract
Globotriaosylsphingosine (lyso-Gb3) is considered as one of the biological marker for Fabry disease. To date, a reli-able biomarker that reflects disease severity and progression has not been discovered to guide the management of Fabry disease. A new method included a simple protein precipitation with acetonitrile in 100 µL of plasma following analyte separation on an Phenomenex Kintex- C18 column using a gradient elution (0.1% formic acid in 5-90% acetonitrile). Total run time was within 12 min including sample preparation and MS/MS analysis. The limit of detection and limit of quantitation were 1 ng/mL and 2 ng/mL, respectively. The calibration curve was linear over the concentration range of 2.0-200.0 ng/mL (r 2 = 0.9999). Inter-day accuracy and precision at 7 level were 93.4-100.7% with RSD of 0.55-5.97%. Absolute recovery was 97.6-98.6%. The method was applied to human and mice plasma, proved the suitability for quantification of lyso-Gb3 for screening, diagnosis and thera-peutic monitoring of Fabry disease patients.
- keywords
- Fabry disease, Globotriaosylsphingosine, Ultraperformance liquid chromatography tandem-mass spectrometry, Inherited metabolic disease.
Reference
1
Desnick, R. J.. (2001). The metabolic and molecular bases of inherited disease:McGraw Hill.
2
Wilcox, W. R,. (2008). . Mol. Genet. Metab, 93, 112-.
3
Whitfield, D. P.. (2005). . J. Inherit. Metab. Dis, 28, 21-.
4
Kitagawa, T.. (2005). . Mol. Genet. Metab, 85, 196-.
5
Rozenfeld, P. A.. (2009). . Clin. Chim. Acta, 403, 194-.
6
Rombach, S. M.. (2010). . Biochim. Biophys. Acta, 1802, 741-.
7
Scheidt, W. V.. (1991). . N. Engl. J. Med, 324, 395-.
8
Kusano, E.. (2014). . Clin. Exp. Nephro, 18, 273-.
9
Gold, H.. (2013). . Clin. Chem, 59, 547-.
10
Togawa, T.. (2010). . Mol. Genet. Metab, 100, 257-.
11
Aerts, J. M.. (2008). . Proc. Natl. Acad. Sci. USA, 105, 2812-.
12
Clarke, J. T.. (2007). . Ann. Intern. Med, 146, 425-.
13
Lavoie, P.. (2013). . Anal. Chem, 85, 1743-.
14
15
Auray-Blais, C.. (2010). . Clin. Chim. Acta, 411, 1906-.
16
Boutin, M.. (2014). . Anal. Chem, 86, 3476-.
17
Dupont, F. O.. (2013). . Curr. Med.Chem, 20, 280-.
18
Auray-Blais, C.. (2015). . Clin. Chem. Acta, 438, 195-.
19
Britt Johnson. (2013). Analysis of Lyso-Globotriaosylsphingosine in Dried Blood Spots. Annals of Laboratory Medicine, 33(4), 274-278.
20
21
Causon, R.. (1997). . J. Chromatogr. B, 689, 175-.
22
Kruger, R.. (2012). . J. Chromatogr. B, 833, 128-.
23
Young, E.. (2005). . Acta. Paediatr, 94, 51-.
24
Fan, J. Q.. (2003). . Methods Enzymol, 363, 412-.
25
Fan, J. Q.. (1999). . Nat. Med, 5, 112-.
26
Valenzano, K. J.. (2011). . Assay Drug Dev. Technol, 9, 213-.
27
Togawa, T.. (2010). . Biochim. Biophys. Acta, 399, 716-.
- Submission Date
- 2015-11-23
- Revised Date
- 2015-11-25
- Accepted Date
- 2015-11-25
Other articles from this issue
- Analytical Techniques Using ICP-MS for Clinical and Biological Analysis
- Applications of Stochastic Process in the Quadrupole Ion traps
- Mass Spectrometric Analysis for Discrimination of Diastereoisomers
- Mass Fragmentation Patterns as Fingerprints for Positive Identification of Polyphenolic Compounds in a Crude Extract
- Investigation of Ne and He Buffer Gases Cooled Ar + Ion Clouds in a Paul Ion Trap
- A Fast Determination of Globotriaosylsphingosine in Plasma for Screening Fabry Disease Using UPLC-ESI-MS/MS
- more
Recommanded Articles
This website recommended the use the Chrome browser for journal website.